CN111067996A - 用于制备缓解疼痛药物的组合物及药物制备方法 - Google Patents
用于制备缓解疼痛药物的组合物及药物制备方法 Download PDFInfo
- Publication number
- CN111067996A CN111067996A CN202010039179.7A CN202010039179A CN111067996A CN 111067996 A CN111067996 A CN 111067996A CN 202010039179 A CN202010039179 A CN 202010039179A CN 111067996 A CN111067996 A CN 111067996A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- pellets
- pain
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了用于制备缓解疼痛药物的组合物,包括白杨树皮、川芎、姜黄素、龙腹香、制附子、鱼骨素、野山参、补骨脂、透骨草、独椒、刺果番荔枝、天南星、血竭、乳香、没药、巴西人参果、樟脑;本组合物可以添加合适的辅料,制成适合内服或外用口服液、贴剂、涂抹剂、缓释剂等剂型。
Description
技术领域
本发明涉及医药领域,具体是用于制备缓解疼痛药物的组合物及药物制备方法。
背景技术
流行病学调查显示85%以上的成年人都有不同程度的痛症,目前疼痛患者逐年上升、并年轻化,每年经济损失费高达17亿多。大约3%以上因关节、腰腿严重疼痛而病退或离职,据不完全统计97%以上患者均属类风湿及痛风所致死忘或致残。类风湿及痛风,西医治疗除用激素消炎止痛外,尚无特效药物治疗,而口服西药毒副反应及大,严重影响肝肾及造血功能。
目前仍没有治疗风湿痺痛的统一标准,随着医学科研枝术不断发展,开发出透皮给药、渗透性强、见效快、作用持久、安全可靠疗效肯定、毒副作用小、针对性强、使用方便,药源广而价兼易得等优点的中药外用制剂,为将来治疗癌症晚期、风湿病痛及痛风开辟了新的途径。
发明内容
本发明的目的是用于制备缓解疼痛药物的组合物及药物制备方法,本发明是组合物制成的药物,具有祛风除湿、消炎止痛、舒筋活络、特别是对晚期癌症的疼痛具有显著效果。本发明的药物做成贴剂、涂抹剂,治疗晚期癌症疼痛、类风湿关节炎、风湿性关节炎、风湿性心脏病、痛风及痛风所致的并发症疗效好、副作用小的中药外用制剂。
用于制备缓解疼痛药物的组合物,由以下重量份成分:白杨树皮50~100份、川芎15~20份、姜黄素10~15份、龙腹香0.1~0.3份、制附子10~12份、鱼骨素50~150份、野山参35~50份、补骨脂15~30份、透骨草30~70份、独椒25~30份、刺果番荔枝100~200份、天南星50~100份、血竭50~100份、乳香15~25份、没药15~25份、巴西人参果20~30份、樟脑3~5份。
优选的,用于制备缓解疼痛药物的组合物,由以下重量份成分:白杨树皮80份、川芎18份、姜黄素12份、龙腹香0.2份、制附子11份、鱼骨素100份、野山参40份、补骨脂20份、透骨草50份、独椒28份、刺果番荔枝150份、天南星80份、血竭80份、乳香20份、没药20份、巴西人参果25份、樟脑4份
优选的,所述组合物还包括微晶纤维素30%、硬脂酸镁1%、十二烷基硫酸钠3%、羟丙基甲基纤维素60克、75%乙醇适量、丙二醇3克、聚乙二醇6000,1克。
本组合物可以添加合适的辅料,制成适合内服或外用口服液、贴剂、涂抹剂、缓释剂等剂型。
用于制备缓解疼痛外用药物的制备方法,包括以下制备步骤:
步骤一,按配方量称取原料药材,取配方量90%的天南星、血竭、乳香、没药、用75%乙醇为溶剂,浸渍48小时,以每千克1ml/min的速度渗滤,收集滤液,回收乙醇,并继续浓缩至相对密度为1.08~1.10的浸膏;
步骤二,加入血竭、樟脑及水,并加入剩余10%天南星、姜黄素、乳香、没药等药物,用胶体磨研磨备用,取明胶加水,60度下溶解,加入甘油、硅藻土,与上述天南星等备用溶液混合均匀,制得涂布液;
步骤三,将制得的涂布液涂布、切割、制成贴剂。
一种用于制备缓解疼痛外用药物的制备方法,包括以下制备步骤:
步骤一,按配方量称取原料药材,取配方量取白杨皮提取物、制附子提取物、骨脂原料粉、刺果番荔枝提取物、姜黄素、等原料粉、微晶纤维素、淀粉全部置于流化床中、按照操作参数表参数、喷雾适量蒸馏水进行粘合,待微丸长至一定大小时停喷,并适当干燥。过筛,选取30和60目的微丸;
步骤二,将载药微丸置于沸腾床中,按照操作参数表参数,于载药微丸表面喷上缓释包衣液进行表面封闭。待包衣增重至5%后停喷。在55~60温度下,继续干燥0.5h,即得膜缓释微丸;
步骤三,将30目的微丸装入胶囊、60目的包装微丸、即得中药缓释胶囊和微丸。
性味归经与药理作用:
(1)白杨皮提取物:味苦、酸、寒、无毒。白杨皮类脂(Poplarpid)在医药方面都有着广泛的应用前景。最早记载白杨皮的药用功效及应用范围的药物史著一《本草纲目》的第2037页记载:"(主治)毒风脚肿、四肢缓弱不随、酒浸服之"表明白杨皮在治疗风湿痛症及皮肤疾病方面有一定疗效。(本人对白杨皮治疗风湿性关节炎、类风湿关节炎及痛风、跌打损伤、及各种癌症晚期所致的疼痛,研究和应用有50余年,的确取得成功。帮助数万人解除了疼痛之苦,免除了他、她们的载肢及瘫痪之终身伤害)。
(2)川芎提取物:味辛、性温。归肝、胆、心胞经。具有活血化淤消肿止痛、行气开郁的作用。
(3)龙腹香:味苦、酸、平。归肝、肾二经。具有逐瘀通络、补肝肾壮筋骨、活血止痛的作用。
(4)姜黄素:味苦、辛、温。归肝、脾经。功能,舒经止痛,活血化淤、缓解风湿骨痛、去风除湿、,散寒消肿止痛,如胸闷心痛、冠心病、心绞痛均有治疗作用。
(6)制附子提取物:味辛、甘、大热、生用有毒、一定要九蒸九晒多次炮制方为如药。归心、脾、肾经。功效:有回阳救逆、补火助阳、散寒止痛,逐冷痰,通关节之猛药也。
(7)天南星、味微苦、性温。归肝、胃经。功效:它是化瘀止血、活血止痛之良药。
(8)透骨草:味甘、辛、性温。归肺、肝、肾经。功效:祛风除湿、舒筋活络、散寒消肿、解毒止痛的功效。
(9)障脑味辛、苦、微寒。归心、脾、肺经。功效:开窍醒神、清热止痛的功效。
(10)刺果番荔枝味甜、甘、性温。归脾、胃、肝、肾经。功效:防病抗癌、消肿止痛之功效。五药共为臣。
(11)独椒辛、热。归脾、胃、肾经。功效:温中散寒止痛、燥湿杀虫止痒。
(12)血竭性平、味甘、咸。归心、肝经。功效:祛瘀定痛、止血生肌、活血化淤、消肿散结等作用。
(13)乳香、没药苦、平。归心、肝、脾经。功效:活血止痛、消肿生肌长肉。上四味共为佐药。
(14)鱼骨素具有丰富的营养价值、鱼骨素含有特殊成分可增强人体免疫力及记忆力、鱼骨素含有钙元素和人体所需的微量元素、且容易被人体吸收。
而众药配伍使用、疗效更佳。
本发明的有益效果:
该组合物制成的药物可促进骨髓细胞造血功能,具有生精补气血之作用,适用于各种原因所致的气血两虚之人群,特别对瘤患者因放化疗引起造血细胞功能低下最为适宜。也可用于各种贫血及免疫系统疾病均有辅助治疗作用。祛风散寒除湿、活络止痛、消种散结、改善身体内外痛症、特别对晚期癌症、痛风、风湿性关节炎、心绞痛等均有治疗作用。
具体实施例
以下结合具体实施例对本发明作进一步说明:
实施例1,将组合物制成口服液:
将白杨树皮50~100份、川芎秦15~20份、姜黄素10~15份、龙腹香0.1~0.3份、制附子10~12份、鱼骨素50~150份、野山参35~50份、补骨脂15~30份、透骨草30~70份、独椒25~30份、刺果番荔枝100~200份、天南星50~100份、血竭50~100份、乳香15~25份、没药15~25份、巴西人参果20~30份、樟脑3~5份;制成口服液;
制备方法如下:(1)将白杨树皮、川芎、姜黄素、龙腹香、制附子、鱼骨素、野山参、补骨脂、透骨草、独椒、刺果番荔枝、天南星、血竭、乳香、没药、巴西人参果、樟脑粉碎;
(2)称取以上重量的原料粉加蒸馏水搅拌提取,温度控制在80度,时间1小时,滤过,滤渣加水,80度提取0.5h,滤过、合并滤液,80度减压浓缩。
(3)调配:将以上浓缩液混合均匀、加入麦芽低聚糖和葡萄糖,滤过,灭菌消毒,灌装,即得。
实施例2,将组合物制成贴剂、涂抹剂:
取总量的90%的白杨树皮、川芎、姜黄素、龙腹香、制附子、鱼骨素、野山参、补骨脂、透骨草、独椒、刺果番荔枝、天南星、乳香、没药、巴西人参果,用75%乙醇为溶剂,浸渍48小时,以每千克1ml/min的速度渗滤,收集滤液,回收乙醇,并继续浓缩至相对密度为1.08~1.10的浸膏,加入血竭、障脑,并加入剩余10%白杨树皮、川芎、姜黄素、龙腹香等药物,用胶体磨研磨备用,取明胶加水,60度下溶解,加入甘油、硅藻土,与上述天南星等备用溶液混合均匀,涂布、切割、即成贴剂。
涂抹剂制法:将原料药材按配比参数称取,加9倍量水煎煮2-3小时提取3次、滤过,滤查再加3倍水煎煮2小时,滤过,合并滤液,减压浓缩至相对密度为1.13~1.17(85℃)的稠膏,加乙醇使药液含乙醇量达75%,加入聚乙烯醇缩甲乙酫、加入75%乙醇浸泡膨胀后,使其完全溶解,搅匀备用,将醇沉液加入独椒提取物后与基质充分搅拌均匀,加75%乙醇调整总量至1000克,包装即得涂抹剂。
本产品采用水溶性透皮性基质,通过外用作用于癌痛部位经皮吸收,有利于药物发挥有效止痛消肿、对晚期癌症患者可有效改善疼痛。
实施例3,将组合物制成缓释制剂:
将以上白杨皮、制附子、骨脂、刺果番荔枝、姜黄素、等原料提取物粉、微晶纤维素、淀粉全部置于流化床中、按照操作参数表参数、喷雾适量蒸馏水进行粘合,控制微丸在0.18~0.22克左右停喷,并适当干燥。过筛,选取30-60目之间微丸。
(3)将载药微丸置于沸腾床中,按照操作参数表参数,于载药微丸表面喷上缓释包衣液进行表面封闭。待包衣增重至5%后停喷。在55~60温度下,继续干燥0.5h,即得膜缓释微丸。将30目的微丸装入胶囊、60目的包装微丸、即得中药缓释胶囊和微丸。
特点:本品制备的缓释技术能有效控制药物在一定时间内释放,维持24小时的有效血药浓度,无突释现象,并对胃、肠、肝、脾无刺激及其不良反应。
疗效观察:
参照实施例2涂抹剂,分别用于一、二组,在疼痛处涂抹药剂,每天2~3次,疼痛严重者(24小时内可涂抹5~6次),20天为一疗程。经两个疗程治疗,所有患者的疼痛都有明显好转,在用药过程中未见不良反应。六年内的患者42人、走路改善、疼痛感消失,停药也无复发反应。
十年内的患者8人,经4个疗程的治疗后7人基本痊愈,一人因腰椎间盘突出症所致出现腿痛外其他症状明显好转。效果总结:显著效果85%、有效率98%,效果不明显3%。从实列看出本中药配方具有见效快、成本低安全可靠,毒副作用小等优点。
验案观察:
用于晚期癌痛(门诊部分患者统计)46例,结果显效(疼痛消失)37例,好转(疼痛减轻)19例,无效2例、总有效率98%。
典型病例,陆太太56岁、于2018年3月5日晚上9点就诊,自诉,近两天腹部剧痛难忍,无法饮食,夜间疼痛更剧,曾去两家肿瘤医院检查,确诊为巨块型肝癌,不予治疗。刻下:面黄如纸、肌瘦皮包骨,皮肤巩膜具黄,精神及差。听诊:心肺正常,肝大于脐下,质偏硬呈结节状,腹部CT,报告:巨块型肝癌。诊其脉象,六脉沉滞,舌淡苔白质灰暗有瘀斑,诊断为气滞血瘀,痰聚湿阻。见患者痛苦难忍,当时就给予(实施例2)外贴,内服(实施例3)微丸、35分钟左右开始痛减,每张膏药贴3~5天换,微丸一天1~2次,每次5~7粒,共治疗58天肝脏由肚脐下5厘米缩小到肚脐上7厘米,饮食如常,治疗前体重53千克,经治疗58天后体重增加到69千克。治疗前无法活动,治疗后能到公园散步及开车1小时不觉疲劳。带瘤生存5年之多,随访仍然健康无复发。
Claims (4)
1.用于制备缓解疼痛药物的组合物,其特征在于,所述组合物由以下重量份成分:白杨树皮50~100份、川芎15~20份、姜黄素10~15份、龙腹香0.1~0.3份、制附子10~12份、鱼骨素50~150份、野山参35~50份、补骨脂15~30份、透骨草30~70份、独椒25~30份、刺果番荔枝100~200份、天南星50~100份、血竭50~100份、乳香15~25份、没药15~25份、巴西人参果20~30份、樟脑3~5份。
2.根据权利要求1所述的用于制备缓解疼痛药物的组合物,其特征在于所述组合物由以下重量份成分:白杨树皮80份、川芎18份、姜黄素12份、龙腹香0.2份、制附子11份、鱼骨素100份、野山参40份、补骨脂20份、透骨草50份、独椒28份、刺果番荔枝150份、天南星80份、血竭80份、乳香20份、没药20份、巴西人参果25份、樟脑4份。
3.用于制备缓解疼痛外用药物的制备方法,其特征在于,包括以下制备步骤:
步骤一,按配方量称取原料药材,取配方量90%的天南星、血竭、乳香、没药、用75%乙醇为溶剂,浸渍48小时,以每千克1ml/min的速度渗滤,收集滤液,回收乙醇,并继续浓缩至相对密度为1.08~1.10的浸膏;
步骤二,加入樟脑5克、蒸馏水25毫升,并加入剩余10%天南星、姜黄素、乳香、没药等药物,用胶体磨研磨备用,取明胶加水,60度下溶解,加入甘油、硅藻土,与上述天南星等备用溶液混合均匀,制得涂布液;
步骤三,将制得的涂布液涂布、切割、制成贴剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010039179.7A CN111067996A (zh) | 2020-01-14 | 2020-01-14 | 用于制备缓解疼痛药物的组合物及药物制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010039179.7A CN111067996A (zh) | 2020-01-14 | 2020-01-14 | 用于制备缓解疼痛药物的组合物及药物制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111067996A true CN111067996A (zh) | 2020-04-28 |
Family
ID=70323151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010039179.7A Pending CN111067996A (zh) | 2020-01-14 | 2020-01-14 | 用于制备缓解疼痛药物的组合物及药物制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111067996A (zh) |
-
2020
- 2020-01-14 CN CN202010039179.7A patent/CN111067996A/zh active Pending
Non-Patent Citations (1)
Title |
---|
陈仁寿: "《中医肿瘤科处方手册》", 31 January 2006, 科学技术文献出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200147165A1 (en) | Composition and method for preparing pain relieving drug | |
CN101926882A (zh) | 治疗癌症的药物组合物及其制备方法 | |
CN104491220B (zh) | 一种治疗带状疱疹的中药组合物 | |
CN105056159A (zh) | 一种治疗猪寄生虫病的药物及其制备方法 | |
CN105056192A (zh) | 一种治疗心肌梗死的中药组合物及其应用 | |
CN103656048A (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
KR20140143952A (ko) | 면역력 및 혈액순환 개선 기능을 갖는 관절염 치료 조성물과 그 제조방법 | |
CN111067996A (zh) | 用于制备缓解疼痛药物的组合物及药物制备方法 | |
CN106729429A (zh) | 一种活血化瘀的中药组合物及其制备方法 | |
CN105664053A (zh) | 一种治疗维持性血液透析患者动静脉内瘘穿刺处皮肤硬结的中药组合物 | |
CN103083488B (zh) | 一种用于治疗骨病的中药组合物及其制剂 | |
CN105832787A (zh) | 一种三七西洋参复合制剂及其制备方法与应用 | |
CN101987135A (zh) | 一种治疗破伤风的药物及其制备方法 | |
CN101518579B (zh) | 一种稳压疏通药及制备工艺 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN104666671A (zh) | 一种红豆杉抗癌止痛药物及其制作方法 | |
CN104352866A (zh) | 一种治疗火毒伤津型烧伤的中药制剂及其制备方法 | |
CN108904656A (zh) | 治疗颈椎病或腰椎病的药物组合物及其制备方法和用途 | |
CN103690771B (zh) | 用于治疗羔羊大肠杆菌病的药物及其制备方法 | |
KR101543760B1 (ko) | 중풍 및 혈전 치료, 예방용 약재 조성물 | |
CN105687530A (zh) | 一种抗癌药及其制备方法、用途 | |
CN104940710A (zh) | 天竺黄痫康宁中药组合物及其制备方法 | |
CN105055865B (zh) | 一种骨伤活血鹿茸胶囊 | |
CN104225506A (zh) | 用于治疗化疗后血小板减少的药物制剂 | |
CN104398849A (zh) | 一种治疗头晕的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200428 |
|
RJ01 | Rejection of invention patent application after publication |